# Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas

> **NCT02379572** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 315 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** iMRI-guided surgery
- **DRUG:** 5-ALA-guided surgery

## Key facts

- **NCT ID:** NCT02379572
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2020-06
- **Final completion:** 2021-07-01
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379572, "Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02379572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*